Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
372 | 3571 | 44.8 | 73% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
124 | 3 | PARKINSONS DISEASE//MOVEMENT DISORDERS//DEEP BRAIN STIMULATION | 67777 |
166 | 2 | PARKINSONS DISEASE//MOVEMENT DISORDERS//MULTIPLE SYSTEM ATROPHY | 22593 |
372 | 1 | DYSKINESIA//LEVODOPA//MOTOR FLUCTUATIONS | 3571 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | DYSKINESIA | authKW | 2047278 | 15% | 43% | 552 |
2 | LEVODOPA | authKW | 1328519 | 14% | 30% | 512 |
3 | MOTOR FLUCTUATIONS | authKW | 1017245 | 5% | 62% | 193 |
4 | PARKINSONS DISEASE | authKW | 599988 | 41% | 5% | 1451 |
5 | DOPAMINE AGONISTS | authKW | 505126 | 7% | 23% | 261 |
6 | MOTOR COMPLICATIONS | authKW | 486731 | 2% | 65% | 88 |
7 | L DOPA | authKW | 465735 | 8% | 19% | 288 |
8 | L DOPA INDUCED DYSKINESIA | authKW | 290447 | 2% | 59% | 58 |
9 | ROPINIROLE | authKW | 278949 | 2% | 40% | 82 |
10 | CONTINUOUS DOPAMINERGIC STIMULATION | authKW | 276347 | 1% | 79% | 41 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Clinical Neurology | 63403 | 57% | 0% | 2053 |
2 | Neurosciences | 11622 | 34% | 0% | 1219 |
3 | Pharmacology & Pharmacy | 5566 | 25% | 0% | 880 |
4 | Psychiatry | 846 | 7% | 0% | 236 |
5 | Medicine, General & Internal | 284 | 6% | 0% | 209 |
6 | Geriatrics & Gerontology | 164 | 1% | 0% | 51 |
7 | Behavioral Sciences | 37 | 1% | 0% | 43 |
8 | Primary Health Care | 6 | 0% | 0% | 8 |
9 | Chemistry, Medicinal | 2 | 1% | 0% | 37 |
10 | Medicine, Research & Experimental | 0 | 1% | 0% | 50 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BASAL GANGLIA PATHOPHYSIOL UNIT | 189944 | 1% | 56% | 40 |
2 | MANCHESTER MOVEMENT DISORDER | 57779 | 0% | 52% | 13 |
3 | EXPT THER EUT BRANCH | 43284 | 1% | 16% | 32 |
4 | MOVEMENT DISORDER CLIN | 39732 | 1% | 23% | 20 |
5 | PARKINSONS DIS MOVEMENT DISORDERS | 35334 | 1% | 12% | 36 |
6 | SERV NEUROL NEUROL EXPT | 34196 | 0% | 100% | 4 |
7 | NEUROL | 28086 | 26% | 0% | 915 |
8 | CIC9302 | 27919 | 0% | 47% | 7 |
9 | CLIN INVEST CIC9302 | 25647 | 0% | 100% | 3 |
10 | NDRG | 25647 | 0% | 100% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLINICAL NEUROPHARMACOLOGY | 198884 | 7% | 10% | 236 |
2 | MOVEMENT DISORDERS | 126836 | 9% | 5% | 311 |
3 | PARKINSONISM & RELATED DISORDERS | 39269 | 3% | 4% | 105 |
4 | NEUROLOGY | 37854 | 9% | 1% | 307 |
5 | JOURNAL OF NEURAL TRANSMISSION | 15752 | 2% | 2% | 87 |
6 | AKTUELLE NEUROLOGIE | 15459 | 2% | 3% | 57 |
7 | ANNALS OF NEUROLOGY | 9168 | 3% | 1% | 92 |
8 | JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT | 8419 | 1% | 4% | 28 |
9 | EUROPEAN NEUROLOGY | 6691 | 1% | 1% | 53 |
10 | ADVANCES IN NEUROLOGY | 6667 | 1% | 4% | 20 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DYSKINESIA | 2047278 | 15% | 43% | 552 | Search DYSKINESIA | Search DYSKINESIA |
2 | LEVODOPA | 1328519 | 14% | 30% | 512 | Search LEVODOPA | Search LEVODOPA |
3 | MOTOR FLUCTUATIONS | 1017245 | 5% | 62% | 193 | Search MOTOR+FLUCTUATIONS | Search MOTOR+FLUCTUATIONS |
4 | PARKINSONS DISEASE | 599988 | 41% | 5% | 1451 | Search PARKINSONS+DISEASE | Search PARKINSONS+DISEASE |
5 | DOPAMINE AGONISTS | 505126 | 7% | 23% | 261 | Search DOPAMINE+AGONISTS | Search DOPAMINE+AGONISTS |
6 | MOTOR COMPLICATIONS | 486731 | 2% | 65% | 88 | Search MOTOR+COMPLICATIONS | Search MOTOR+COMPLICATIONS |
7 | L DOPA | 465735 | 8% | 19% | 288 | Search L+DOPA | Search L+DOPA |
8 | L DOPA INDUCED DYSKINESIA | 290447 | 2% | 59% | 58 | Search L+DOPA+INDUCED+DYSKINESIA | Search L+DOPA+INDUCED+DYSKINESIA |
9 | ROPINIROLE | 278949 | 2% | 40% | 82 | Search ROPINIROLE | Search ROPINIROLE |
10 | CONTINUOUS DOPAMINERGIC STIMULATION | 276347 | 1% | 79% | 41 | Search CONTINUOUS+DOPAMINERGIC+STIMULATION | Search CONTINUOUS+DOPAMINERGIC+STIMULATION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HUOT, P , JOHNSTON, TH , KOPRICH, JB , FOX, SH , BROTCHIE, JM , (2013) THE PHARMACOLOGY OF L-DOPA-INDUCED DYSKINESIA IN PARKINSON'S DISEASE.PHARMACOLOGICAL REVIEWS. VOL. 65. ISSUE 1. P. 171 -222 | 282 | 50% | 79 |
2 | BASTIDE, MF , MEISSNER, WG , PICCONI, B , FASANO, S , FERNAGUT, PO , FEYDER, M , FRANCARDO, V , ALCACER, C , DING, YM , BRAMBILLA, R , ET AL (2015) PATHOPHYSIOLOGY OF L-DOPA-INDUCED MOTOR AND NON-MOTOR COMPLICATIONS IN PARKINSON'S DISEASE.PROGRESS IN NEUROBIOLOGY. VOL. 132. ISSUE . P. 96 -168 | 343 | 34% | 25 |
3 | SCHAEFFER, E , PILOTTO, A , BERG, D , (2014) PHARMACOLOGICAL STRATEGIES FOR THE MANAGEMENT OF LEVODOPA-INDUCED DYSKINESIA IN PATIENTS WITH PARKINSON'S DISEASE.CNS DRUGS. VOL. 28. ISSUE 12. P. 1155 -1184 | 209 | 67% | 6 |
4 | NYHOLM, D , (2006) PHARMACOKINETIC OPTIMISATION IN THE TREATMENT OF PARKINSON'S DISEASE - AN UPDATE.CLINICAL PHARMACOKINETICS. VOL. 45. ISSUE 2. P. 109 -136 | 172 | 69% | 98 |
5 | JENNER, P , (2008) PREVENTING AND CONTROLLING DYSKINESIA IN PARKINSON'S DISEASE - A VIEW OF CURRENT KNOWLEDGE AND FUTURE OPPORTUNITIES.MOVEMENT DISORDERS. VOL. 23. ISSUE . P. S585-S598 | 139 | 77% | 31 |
6 | JENNER, P , (2008) MOLECULAR MECHANISMS OF L-DOPA-INDUCED DYSKINESIA.NATURE REVIEWS NEUROSCIENCE. VOL. 9. ISSUE 9. P. 665 -677 | 110 | 60% | 229 |
7 | JENNER, P , (2013) WEARING OFF, DYSKINESIA, AND THE USE OF CONTINUOUS DRUG DELIVERY IN PARKINSON'S DISEASE.NEUROLOGIC CLINICS. VOL. 31. ISSUE 3. P. S17-+ | 91 | 88% | 6 |
8 | JOHNSTON, TH , LANE, EL , (2011) EXPERIMENTAL MODELS OF L-DOPA-INDUCED DYSKINESIA.PATHOPHYSIOLOGY, PHARMACOLOGY, AND BIOCHEMISTRY OF DYSKINESIA. VOL. 98. ISSUE . P. 55 -93 | 125 | 64% | 1 |
9 | VIJAYAKUMAR, D , JANKOVIC, J , (2016) DRUG-INDUCED DYSKINESIA, PART 1: TREATMENT OF LEVODOPA-INDUCED DYSKINESIA.DRUGS. VOL. 76. ISSUE 7. P. 759 -777 | 94 | 69% | 1 |
10 | BLANDINI, F , ARMENTERO, MT , (2014) DOPAMINE RECEPTOR AGONISTS FOR PARKINSON'S DISEASE.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 23. ISSUE 3. P. 387 -410 | 110 | 62% | 7 |
Classes with closest relation at Level 1 |